Guggenheim Capital’s abrdn Healthcare Opportunities Fund THQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-10,422
| Closed | -$175K | – | 1771 |
|
|
2026
Q1 | $175K | Sell |
10,422
-4,554
| -30% | -$85.6K | ﹤0.01% | 1534 |
|
|
2025
Q4 | $286K | Sell |
14,976
-10,436
| -41% | -$191K | ﹤0.01% | 1550 |
|
|
2025
Q3 | $439K | Sell |
25,412
-11,417
| -31% | -$194K | ﹤0.01% | 1238 |
|
|
2025
Q2 | $677K | Sell |
36,829
-13
| -0% | -$242 | 0.01% | 1037 |
|
|
2025
Q1 | $760K | Buy |
36,842
+66
| +0.2% | +$1.35K | 0.01% | 1002 |
|
|
2024
Q4 | $694K | Sell |
36,776
-8,104
| -18% | -$167K | 0.01% | 1111 |
|
|
2024
Q3 | $991K | Sell |
44,880
-378
| -0.8% | -$8.08K | 0.01% | 1104 |
|
|
2024
Q2 | $922K | Buy |
45,258
+4,134
| +10% | +$82.2K | 0.01% | 1168 |
|
|
2024
Q1 | $827K | Buy |
41,124
+5,323
| +15% | +$102K | 0.01% | 1274 |
|
|
2023
Q4 | $648K | Buy |
35,801
+18,604
| +108% | +$315K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $292K | Buy |
17,197
+189
| +1% | +$3.51K | ﹤0.01% | 1635 |
|
|
2023
Q2 | $324K | Sell |
17,008
-285
| -2% | -$5.37K | ﹤0.01% | 1635 |
|
|
2023
Q1 | $324K | Buy |
+17,293
| New | +$331K | ﹤0.01% | 1657 |
|
|
2022
Q3 | – | Sell |
-16,337
| Closed | -$326K | – | 2041 |
|
|
2022
Q2 | $326K | Sell |
16,337
-5,201
| -24% | -$109K | ﹤0.01% | 1743 |
|
|
2022
Q1 | $479K | Sell |
21,538
-4,356
| -17% | -$97.4K | ﹤0.01% | 1703 |
|
|
2021
Q4 | $664K | Sell |
25,894
-11,092
| -30% | -$266K | ﹤0.01% | 1546 |
|
|
2021
Q3 | $838K | Buy |
36,986
+40
| +0.1% | +$964 | 0.01% | 1509 |
|
|
2021
Q2 | $853K | Sell |
36,946
-803
| -2% | -$18.4K | 0.01% | 1572 |
|
|
2021
Q1 | $820K | Buy |
37,749
+1,563
| +4% | +$32.8K | 0.01% | 1492 |
|
|
2020
Q4 | $737K | Sell |
36,186
-4,177
| -10% | -$79.8K | ﹤0.01% | 1478 |
|
|
2020
Q3 | $730K | Buy |
40,363
+1,513
| +4% | +$27.5K | 0.01% | 1330 |
|
|
2020
Q2 | $692K | Sell |
38,850
-9,728
| -20% | -$172K | 0.01% | 1346 |
|
|
2020
Q1 | $746K | Buy |
48,578
+5,457
| +13% | +$96K | 0.01% | 1218 |
|
|
2019
Q4 | $823K | Buy |
43,121
+4,821
| +13% | +$87.3K | 0.01% | 1422 |
|
|
2019
Q3 | $669K | Sell |
38,300
-10,445
| -21% | -$183K | 0.01% | 1500 |
|
|
2019
Q2 | $869K | Sell |
48,745
-2,367
| -5% | -$40.6K | 0.01% | 1412 |
|
|
2019
Q1 | $901K | Buy |
51,112
+6,826
| +15% | +$119K | 0.01% | 1434 |
|
|
2018
Q4 | $743K | Buy |
44,286
+13,369
| +43% | +$237K | 0.01% | 1503 |
|
|
2018
Q3 | $579K | Buy |
30,917
+6,630
| +27% | +$120K | ﹤0.01% | 1901 |
|
|
2018
Q2 | $413K | Buy |
24,287
+6,613
| +37% | +$111K | ﹤0.01% | 2053 |
|
|
2018
Q1 | $291K | Buy |
17,674
+2,894
| +20% | +$50.5K | ﹤0.01% | 2536 |
|
|
2017
Q4 | $259K | Buy |
14,780
+4,764
| +48% | +$84.7K | ﹤0.01% | 2526 |
|
|
2017
Q3 | $186K | Buy |
+10,016
| New | +$184K | ﹤0.01% | 2617 |
|
Other funds holding THQ
HBCM
PCM
WS
Guggenheim Capital's THQ Position: Q2 2026 in Review
Guggenheim Capital sold out of abrdn Healthcare Opportunities Fund (THQ) in Q2 2026, closing a stake of 10,422 shares — an estimated $175K sold.
Guggenheim Capital first reported a position in THQ in Q3 2017 and held it in 33 quarters. The position peaked at $991K in Q3 2024. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.
- Guggenheim Capital reported no remaining abrdn Healthcare Opportunities Fund position as of Q2 2026 after selling out during the quarter.
- Guggenheim Capital sold 10,422 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $175K.
- Guggenheim Capital first reported a position in abrdn Healthcare Opportunities Fund in Q3 2017 and held it in 33 quarters.
- Guggenheim Capital's abrdn Healthcare Opportunities Fund position peaked at $991K in Q3 2024.
- 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.